SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-766839
Filing Date
2016-11-14
Accepted
2016-11-14 06:35:44
Documents
38
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d96486d10q.htm 10-Q 236362
2 EX-31.1 d96486dex311.htm EX-31.1 6425
3 EX-31.2 d96486dex312.htm EX-31.2 6459
4 EX-32.1 d96486dex321.htm EX-32.1 4701
  Complete submission text file 0001193125-16-766839.txt   1550921

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT matn-20160930.xml EX-101.INS 253863
6 XBRL TAXONOMY EXTENSION SCHEMA matn-20160930.xsd EX-101.SCH 21659
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE matn-20160930_cal.xml EX-101.CAL 25817
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE matn-20160930_def.xml EX-101.DEF 41579
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE matn-20160930_lab.xml EX-101.LAB 181590
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE matn-20160930_pre.xml EX-101.PRE 116286
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 161990290
SIC: 2836 Biological Products, (No Diagnostic Substances)